J Randolph Hecht Selected Research

J Randolph Hecht Research Topics

Disease

30	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 04/2002
24	Neoplasms (Cancer) 03/2024 - 02/2003
14	Adenocarcinoma 06/2023 - 02/2003
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 02/2003
5	Colonic Neoplasms (Colon Cancer) 01/2021 - 11/2004
4	Diarrhea 02/2016 - 04/2002
4	Disease Progression 06/2015 - 03/2007
3	Carcinoma (Carcinomatosis) 01/2023 - 04/2002
3	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2003
3	Neutropenia 06/2015 - 04/2010
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 11/2017
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 02/2008
2	Breast Neoplasms (Breast Cancer) 06/2017 - 11/2004
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 06/2015
2	Hypertension (High Blood Pressure) 12/2012 - 06/2005
2	Infections 04/2010 - 02/2009
2	Stomach Neoplasms (Stomach Cancer) 03/2010 - 05/2006
1	Inflammation (Inflammations) 03/2024
1	Hematologic Neoplasms (Hematological Malignancy) 06/2023
1	Lymphatic Metastasis 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Microsatellite Instability 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 07/2015
1	Dehydration (Water Stress) 06/2015
1	Hypotension (Low Blood Pressure) 06/2015
1	Hypokalemia 06/2015
1	Melanoma (Melanoma, Malignant) 01/2015
1	Hypoxia (Hypoxemia) 05/2011
1	Febrile Neutropenia 04/2010

Drug/Important Bio-Agent (IBA)

15	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 09/2007
15	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 03/2003
13	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 04/2002
12	Leucovorin (Folinic Acid)FDA Link 01/2021 - 06/2005
12	Panitumumab (Vectibix)FDA Link 08/2017 - 01/2006
11	ErbB Receptors (EGF Receptor)IBA 01/2019 - 11/2006
11	Bevacizumab (Avastin)FDA Link 08/2017 - 06/2005
7	Monoclonal AntibodiesIBA 01/2017 - 06/2005
5	Capecitabine (Xeloda)FDA Link 06/2017 - 12/2012
4	Gemcitabine FDA Link 01/2021 - 02/2003
4	Lapatinib (GW572016)FDA Link 06/2017 - 03/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015 - 06/2005
2	IpilimumabIBA 03/2024 - 01/2022
2	Immune Checkpoint InhibitorsIBA 03/2024 - 06/2023
2	NivolumabIBA 03/2024 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2015
2	pegilodecakinIBA 01/2021 - 01/2021
2	Carcinoembryonic AntigenIBA 11/2020 - 10/2017
2	Angiogenesis InhibitorsIBA 01/2019 - 05/2011
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2017 - 01/2017
2	simtuzumabIBA 01/2017 - 01/2017
2	Codon (Codons)IBA 09/2015 - 07/2014
2	Cetuximab (Erbitux)FDA Link 09/2015 - 03/2015
2	Epidermal Growth Factor (EGF)IBA 09/2015 - 07/2007
2	Everolimus FDA Link 07/2015 - 03/2015
2	AntibodiesIBA 06/2015 - 05/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 02/2008
2	Sunitinib (Sutent)FDA Link 01/2015 - 03/2008
2	vatalanib (PTK787)IBA 05/2011 - 05/2011
2	Imatinib Mesylate (Gleevec)FDA Link 03/2008 - 02/2008
2	Cisplatin (Platino)FDA LinkGeneric 05/2006 - 04/2002
2	dl1520 (ONYX-015)IBA 04/2003 - 02/2003
1	Messenger RNA (mRNA)IBA 03/2024
1	Combined VaccinesIBA 03/2024
1	VaccinesIBA 03/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2024
1	16S Ribosomal RNAIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	talazoparibIBA 01/2023
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2022
1	InterleukinsIBA 01/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	gallium Ga 68 dotatateIBA 11/2017
1	labetuzumab govitecanIBA 10/2017
1	Cell Adhesion MoleculesIBA 10/2017
1	Immunoconjugates (Immunoconjugate)IBA 10/2017
1	Proton Pump InhibitorsIBA 06/2017
1	EnzymesIBA 01/2017
1	Epirubicin (Ellence)FDA LinkGeneric 01/2017
1	human ERBB2 proteinIBA 02/2016
1	talimogene laherparepvecIBA 01/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 10/2014
1	XELOXIBA 12/2012
1	Lactate Dehydrogenase 5IBA 05/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2011
1	pegfilgrastim (Neulasta)FDA Link 04/2010
1	Proteins (Proteins, Gene)FDA Link 03/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2010

Therapy/Procedure

19	Therapeutics 08/2023 - 02/2003
16	Drug Therapy (Chemotherapy) 01/2023 - 04/2003
2	Immunotherapy 06/2023 - 01/2015
2	Radiotherapy 10/2022 - 02/2012
1	Neoadjuvant Therapy 10/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Adjuvant Chemotherapy 12/2012
1	Cutaneous Administration 02/2012
1	Chemoradiotherapy 02/2012